Fifth Third Bancorp
- SEC CIK
- 0000035527
- Latest filing
- Aug 5, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −3,300−100.0% | Sold out | Holders |
| Q2 2025 | 3,300 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,300 | $6.34K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,300 | $6.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3,300 | $4.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,300 | $3.37K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,300 | $6.04K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,300 | $4.09K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,300 | $3.76K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,300 | $3.02K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,300 | $1.85K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,300 | $1.90K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,300 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,300 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,300 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 3,300 | $7.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,300 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,300 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,300 | $11.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.